Coronado Bioscis.Next HIT

CORONADO BIOSCIENCES INC. REGISTERED SHARES DL -,001 (WKN A1JRZP)

ist ein sehr schöner Wert
Es wird hier derzeit über einen Short Squezze spekuliert der wohl kurz bevor stehen wird .

Absturz im Oktober wie Ariad zumindest vom Chart her.

sieht so aus stimme dir zu naja wenn wir die selbe Stor hier uch bekommen sind wir hier am anfang ;-)

splashurl.com/kyb5qwd

splashurl.com/lp82k3t

splashurl.com/mqhkcdu

splashurl.com/ltuw8kx

heron warum machst du das alles mit Splashurl ??

We do not intend to enter into any employment contract with Mr. Weiss addressing his officer position with our Company. However, in connection with his employment as Executive Vice Chairman, Strategic Development, Mr. Weiss will earn an annual salary of $28,275. In addition, on February 20, 2014, we issued Mr. Weiss 3,958,692 shares of restricted common stock of our Company as an inducement to his employment and for services to be rendered to our Company. The issuance, which was made pursuant to a Restricted Stock Issuance Agreement and under Section 4(2) of the Securities Act of 1933, as amended, provides that 16.67% of the shares will vest on each of the first three annual anniversaries of the date of grant, and 10% of the remainder of the shares will vest upon each closing by our Company of a "Corporate Development Transaction" (as such term is defined in the Restricted Stock Issuance Agreement) provided that if any such Corporate Development Transaction occurs prior to February 20, 2019, vesting of such 10% of the remainder of the shares will occur on February 20, 2019 subject to Mr. Weiss's continued employment with our Company. The foregoing description of the Restricted Stock Issuance Agreement is qualified in its entirety by reference to the full and complete terms contained in the Restricted Stock Issuance Agreement, which is filed as Exhibit 10.55 to this Current Report on Form 8-K.

Mr. Weiss, age 47, is currently Co-Portfolio Manager and Partner of Opus Point Partners, LLC, which he joined in 2009. He also serves as Executive Chairman, Interim Chief Executive Officer and President of TG Therapeutics, Inc. (NASDAQ:
TGTX) since 2011. From 2002 to 2009, Mr. Weiss was the Chairman and Chief Executive Officer of Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX), where he helped the company acquire and develop its lead drug Zerenex as well as executed a $100MM+ strategic alliance for Zerenex with JT Tobacco, Inc. and Torii Pharmaceutical Co., Ltd. Mr. Weiss served on the board of directors of National Holdings Corporation (OTD-BB: NHLD) from 2011 to 2012. Mr. Weiss began his professional career as a lawyer with Cravath, Swaine & Moore LLP. He earned his J.D. from Columbia Law School and his B.S. in Finance from The University at Albany. There are no family relationships between Mr. Weiss and any other director or executive officer of our Company.

In addition, on February 20, 2014, our Board appointed Malcolm Hoenlein, age 70, a director of our Board. Mr. Hoenlein will also serve on the Nominating and Corporate Governance Committee of our Board. Since 1986, Mr. Hoenlein has served as Chief Executive Officer and Executive Vice Chairman of the Conference of Presidents of Major American Jewish Organizations, the coordinating body on international and national concerns for 51 national American Jewish organizations. Previously, he served as the founding Executive Director of the Jewish Community Relations Council of Greater New York. Prior to that, he was the founding Executive Director of the Greater New York Conference on Soviet Jewry. A National Defense Fellow at the Near East Center of the University of Pennsylvania, Mr. Hoenlein taught International Relations in the Political Science Department and served as a Middle East specialist at the Foreign Policy Research Institute. In addition, he served on the editorial staff of ORBIS, the Journal of International Affairs. He serves as a director of several companies, including Bank Leumi USA, Eco-Fusion, LabStyle Innovations Corp. (OTCBB: DRIO), Powermat USA and WellSense Technologies. Mr. Hoenlein has a B.A. in Political Science from Temple University and an M.A. in International Relations from the University of Pennsylvania, as well as an Hon. LL.D. from Touro College and an Hon. D.H.L. from Yeshiva University. In connection with his appointment, our Board granted Mr. Hoenlein a restricted stock award of 30,000 shares of common stock under our 2013 Stock Incentive Plan, which will vest equally over three years on each annual anniversary of the date of grant.

doch gut aus  

War nur Spaß.

100% müßen da schon kommen.

Wenn der Zug einmal Fährt, sollte man auch bis zum Ziel mitfahren.

Mag es nur nicht, auf fahrende Züge aufzuspringen.

noch denke ich ist der Zug im Bahnhoff schliesse gerade die vorderen türen ;-)

sehr schön

im Bahnhof bleiben und sich noch einer Wartung unterziehen.
Mir pers. zu heiß da wir schon am oberen BB angekommen sind und
wie man im Chart sieht, die letzten 4 x gings wieder runter.

Ich werde daher mal die Sache vorerst beobachten

NmM

vielleicht kommt es auch hier ganz anders eine BB ist anpassung fähig ;-)

... stimmt die Richtung nicht Master

Na ich wart mal noch den Montag ab

heute ist Fr was verlangst du ausserdem heisst das nicht wenn ich rein bin das die sofort zündet ;-) Ich suche meine Aktien sorgfälltig aus 8 von 10 bringen mir immer Gewinn ;-) ,eine jetzt nicht 5-10 prozent schon mind.40-50 Prozent.Mann muss vor der grossen Masse rein auch wenn es mal 14 tage dauert bis sich da was tut ;-)